Photodisinfection was first commercialized in April 2006 when Ondine launched Periowave™, an adjunctive therapy for the treatment of chronic adult periodontitis (gum disease). Since that time, Ondine’s highly skilled team of microbiologists and engineers has generated a robust pipeline of products and next generation models, and has become the premier source for research and development of photodynamic technologies.
Technology Platform Partnerships
Ondine has licensed its platform technology, Photodisinfection, for use in a variety of applications. Click on the logo for more information.